14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.29 $3.30 Wednesday, 1st May 2024 OCX stock ended at $2.55. This is 2.41% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 2.22% from a day low at $2.50 to a day high of $2.56.
90 days $2.29 $3.30
52 weeks $0.190 $4.61

Historical OncoCyte Corp prices

Date Open High Low Close Volume
Feb 02, 2016 $3.86 $4.21 $3.84 $3.86 52 687
Feb 01, 2016 $4.00 $4.00 $3.57 $3.96 62 432
Jan 29, 2016 $2.70 $4.19 $2.70 $4.15 81 500
Jan 28, 2016 $2.70 $2.76 $2.64 $2.70 26 330
Jan 27, 2016 $2.65 $2.75 $2.58 $2.62 10 070
Jan 26, 2016 $2.45 $2.70 $2.45 $2.66 15 564
Jan 25, 2016 $2.81 $2.90 $2.60 $2.68 13 866
Jan 22, 2016 $2.75 $2.90 $2.70 $2.88 27 829
Jan 21, 2016 $2.80 $2.90 $2.56 $2.76 54 816
Jan 20, 2016 $3.00 $3.13 $2.79 $2.94 46 849
Jan 19, 2016 $3.51 $3.81 $3.07 $3.13 31 420
Jan 15, 2016 $3.64 $3.80 $3.18 $3.51 17 660
Jan 14, 2016 $3.20 $4.00 $2.59 $3.95 92 892
Jan 13, 2016 $4.00 $4.10 $3.67 $3.69 38 322
Jan 12, 2016 $4.90 $5.61 $3.73 $4.11 53 163
Jan 11, 2016 $6.23 $6.23 $4.23 $4.97 92 964
Jan 08, 2016 $8.40 $8.40 $6.98 $6.99 28 754
Jan 07, 2016 $9.00 $9.00 $7.25 $7.25 69 260
Jan 06, 2016 $10.00 $10.00 $8.50 $8.93 31 602
Jan 05, 2016 $8.90 $10.24 $8.60 $10.11 48 548
Click to get the best stock tips daily for free!

About OncoCyte Corp

OncoCyte OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support... OCX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT